Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Immedica Pharma AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 608,159 Less Arrow 407,343 Less Arrow 359,907
Financial expenses 47,876 More Arrow 51,569 Less Arrow 31,149
Earnings before taxes 56,136 Less Arrow 21,790 More Arrow 40,623
EBITDA 156,467 Less Arrow 124,835 More Arrow 151,344
Total assets 1,495,055 Less Arrow 1,027,737 Less Arrow 878,446
Current assets 394,210 Less Arrow 230,832 Less Arrow 228,933
Current liabilities 225,513 Less Arrow 113,244 Less Arrow 82,990
Equity capital 557,599 Less Arrow 440,533 Less Arrow 337,276
- share capital 34 Less Arrow 33 More Arrow 36
Employees (average) 88 Less Arrow 69 Less Arrow 52

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 37.3% More Arrow 42.9% Less Arrow 38.4%
Turnover per employee 6,911 Less Arrow 5,904 More Arrow 6,921
Profit as a percentage of turnover 9.2% Less Arrow 5.3% More Arrow 11.3%
Return on assets (ROA) 7.0% More Arrow 7.1% More Arrow 8.2%
Current ratio 174.8% More Arrow 203.8% More Arrow 275.9%
Return on equity (ROE) 10.1% Less Arrow 4.9% More Arrow 12.0%
Change turnover 198,718 Less Arrow 76,589 Less Arrow 55,996
Change turnover % 49% Less Arrow 23% Less Arrow 18%
Chg. No. of employees 19 Less Arrow 17 Less Arrow 8
Chg. No. of employees % 28% More Arrow 33% Less Arrow 18%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.